Drug intelligence / Profile preview

OvaCyst

Development stage
Unknown
Lead developer
Bimeda
Modality
Peptides
Administration
Intramuscular, Intravenous
01

Overview

OvaCyst is a veterinary injectable formulation of the gonadotropin-releasing hormone (GnRH) analog gonadorelin diacetate tetrahydrate, containing 50 mcg/mL gonadorelin, used in cattle for reproductive management. By mimicking endogenous hypothalamic GnRH, gonadorelin stimulates the anterior pituitary to release luteinizing hormone (LH) and follicle-stimulating hormone (FSH), thereby inducing ovulation and luteinization of follicular ovarian cysts and enabling synchronization of estrous cycles when used in timed artificial insemination (FTAI) protocols with prostaglandin analogs such as cloprostenol sodium.[1][7] It is supplied as a sterile intramuscular or intravenous solution for use by licensed veterinarians in dairy and beef cows for treatment of cystic ovaries and for estrus synchronization programs.[1]

Brand names
OvaCyst
02

Targets

LHCGR (Luteinizing hormone/choriogonadotropin receptor)GnRHR (Gonadotropin-releasing hormone receptor)

Beyond the preview

Go deeper on OvaCyst.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on OvaCyst.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call